I-125 Versus Pd-103 for Low-Risk Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

I-125 Versus Pd-103 for Low-Risk Prostate Cancer

Published:2005-09 Issue:5 Volume:11 Page:385-389
ISSN:1528-9117
Container-title:The Cancer Journal
language:en
Short-container-title:The Cancer Journal

Author:

Herstein Andrew,Wallner Kent,Merrick Gregory,Mitsuyama Hiroki,Armstrong Julius,True Lawrence,Cavanagh William,Butler Wayne

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference14 articles.

1. Permanent implants using Au-198, Pd-103 and I-125: Radiobiological considerations based on the linear quadratic model

2. 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial

3. 1???125 Versus Pd-103 for Low-Risk Prostate Cancer

4. A reappraisal of local anesthesia for prostate brachytherapy

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Event Reporting in Cancer Clinical Trials: Incorporating Patient-Reported Methods. A Systematic Scoping Review;The Patient - Patient-Centered Outcomes Research;2024-04-08

2. Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE Trial;International Journal of Radiation Oncology*Biology*Physics;2023-12

3. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry;Brachytherapy;2023-11

4. Ruthenium, Rhodium, Palladium, and Osmium;Patty's Toxicology;2023-06-29

5. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement;Brachytherapy;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3